Deterioration in cognitive function in children with benign epilepsy of childhood with central temporal spikes treated with sulthiame

Elaine C Wirrell, Elisabeth M S Sherman, Robert Vanmastrigt, Lorie Hamiwka

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

The purpose of this study was to determine if reduction in spike frequency in children with benign epilepsy of childhood with centrotemporal spikes treated with sulthiame correlates with improved neuropsychologic function. Six untreated children (5 boys, 1 girl) with a mean (standard deviation) age of 9.1 years (1.5 years) underwent overnight ambulatory electroencephalograph recording and neuropsychologic evaluation at baseline and after 6 months of sulthiame monotherapy. The Reliable Change Index was used to determine whether a statistically reliable change in neuropsychologic function occurred. All children continued receiving sulthiame monotherapy (dose range, 8.0-9.3 mg/kg per day) for the study period without further seizures. Although spike frequency was reduced in all 6 children (3 showing a decrease to less than 10% of baseline), they all demonstrated significant deterioration in their reading ability, 5 had significant declines in general memory, and more than half had reduction in attention skills and mathematics ability. Although sulthiame was effective at seizure control and significantly reduced spike frequency in children, it was also associated with deterioration in cognitive function.

Original languageEnglish (US)
Pages (from-to)14-21
Number of pages8
JournalJournal of Child Neurology
Volume23
Issue number1
DOIs
StatePublished - Jan 2008
Externally publishedYes

Fingerprint

Cognition
Epilepsy
Aptitude
Seizures
Rolandic Epilepsy
Mathematics
Reading
sulthiame

Keywords

  • Benign rolandic epilepsy
  • Cognitive deterioration
  • Sulthiame

ASJC Scopus subject areas

  • Clinical Neurology
  • Pediatrics, Perinatology, and Child Health

Cite this

Deterioration in cognitive function in children with benign epilepsy of childhood with central temporal spikes treated with sulthiame. / Wirrell, Elaine C; Sherman, Elisabeth M S; Vanmastrigt, Robert; Hamiwka, Lorie.

In: Journal of Child Neurology, Vol. 23, No. 1, 01.2008, p. 14-21.

Research output: Contribution to journalArticle

@article{1fa94b85a3bb48ba950e59567dccb00a,
title = "Deterioration in cognitive function in children with benign epilepsy of childhood with central temporal spikes treated with sulthiame",
abstract = "The purpose of this study was to determine if reduction in spike frequency in children with benign epilepsy of childhood with centrotemporal spikes treated with sulthiame correlates with improved neuropsychologic function. Six untreated children (5 boys, 1 girl) with a mean (standard deviation) age of 9.1 years (1.5 years) underwent overnight ambulatory electroencephalograph recording and neuropsychologic evaluation at baseline and after 6 months of sulthiame monotherapy. The Reliable Change Index was used to determine whether a statistically reliable change in neuropsychologic function occurred. All children continued receiving sulthiame monotherapy (dose range, 8.0-9.3 mg/kg per day) for the study period without further seizures. Although spike frequency was reduced in all 6 children (3 showing a decrease to less than 10{\%} of baseline), they all demonstrated significant deterioration in their reading ability, 5 had significant declines in general memory, and more than half had reduction in attention skills and mathematics ability. Although sulthiame was effective at seizure control and significantly reduced spike frequency in children, it was also associated with deterioration in cognitive function.",
keywords = "Benign rolandic epilepsy, Cognitive deterioration, Sulthiame",
author = "Wirrell, {Elaine C} and Sherman, {Elisabeth M S} and Robert Vanmastrigt and Lorie Hamiwka",
year = "2008",
month = "1",
doi = "10.1177/0883073807307082",
language = "English (US)",
volume = "23",
pages = "14--21",
journal = "Journal of Child Neurology",
issn = "0883-0738",
publisher = "SAGE Publications Inc.",
number = "1",

}

TY - JOUR

T1 - Deterioration in cognitive function in children with benign epilepsy of childhood with central temporal spikes treated with sulthiame

AU - Wirrell, Elaine C

AU - Sherman, Elisabeth M S

AU - Vanmastrigt, Robert

AU - Hamiwka, Lorie

PY - 2008/1

Y1 - 2008/1

N2 - The purpose of this study was to determine if reduction in spike frequency in children with benign epilepsy of childhood with centrotemporal spikes treated with sulthiame correlates with improved neuropsychologic function. Six untreated children (5 boys, 1 girl) with a mean (standard deviation) age of 9.1 years (1.5 years) underwent overnight ambulatory electroencephalograph recording and neuropsychologic evaluation at baseline and after 6 months of sulthiame monotherapy. The Reliable Change Index was used to determine whether a statistically reliable change in neuropsychologic function occurred. All children continued receiving sulthiame monotherapy (dose range, 8.0-9.3 mg/kg per day) for the study period without further seizures. Although spike frequency was reduced in all 6 children (3 showing a decrease to less than 10% of baseline), they all demonstrated significant deterioration in their reading ability, 5 had significant declines in general memory, and more than half had reduction in attention skills and mathematics ability. Although sulthiame was effective at seizure control and significantly reduced spike frequency in children, it was also associated with deterioration in cognitive function.

AB - The purpose of this study was to determine if reduction in spike frequency in children with benign epilepsy of childhood with centrotemporal spikes treated with sulthiame correlates with improved neuropsychologic function. Six untreated children (5 boys, 1 girl) with a mean (standard deviation) age of 9.1 years (1.5 years) underwent overnight ambulatory electroencephalograph recording and neuropsychologic evaluation at baseline and after 6 months of sulthiame monotherapy. The Reliable Change Index was used to determine whether a statistically reliable change in neuropsychologic function occurred. All children continued receiving sulthiame monotherapy (dose range, 8.0-9.3 mg/kg per day) for the study period without further seizures. Although spike frequency was reduced in all 6 children (3 showing a decrease to less than 10% of baseline), they all demonstrated significant deterioration in their reading ability, 5 had significant declines in general memory, and more than half had reduction in attention skills and mathematics ability. Although sulthiame was effective at seizure control and significantly reduced spike frequency in children, it was also associated with deterioration in cognitive function.

KW - Benign rolandic epilepsy

KW - Cognitive deterioration

KW - Sulthiame

UR - http://www.scopus.com/inward/record.url?scp=37449024255&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37449024255&partnerID=8YFLogxK

U2 - 10.1177/0883073807307082

DO - 10.1177/0883073807307082

M3 - Article

C2 - 18184938

AN - SCOPUS:37449024255

VL - 23

SP - 14

EP - 21

JO - Journal of Child Neurology

JF - Journal of Child Neurology

SN - 0883-0738

IS - 1

ER -